Pediatrics
Cholestasis in pediatrics
Cholestasis means bile fails to form or reach the intestine normally. Determine whether bile flow is blocked outside the liver or impaired within it.
Well covered in the main question banks · 48 main-bank entries · 54 linked PDF entries · 0 generated drills
Prerequisites and related lessons
- Liver function tests (LFT)
Curriculum reference · Official College Textbook – Digestive Disorders – Part 2, pp. 345–347. Lesson adapted from Pediatric hepatology and metabolic disease.
Topic map
- Definitionimpaired bile formation or flow
- Intrahepaticinfection, metabolism, duct paucity or transport
- Extrahepaticatresia, cyst, stone, plug or stricture
- Assess severityGGT, ultrasound, synthesis and treatable causes
Scroll the diagram to see all labels.
Mechanism, bilirubin and presentation
Bilirubin from heme breakdown is initially unconjugated, albumin-bound and poorly water-soluble. Hepatocytes conjugate it to make it water-soluble, then excrete it into bile. Cholestasis is impaired bile formation or flow [Old p. 78 Q19]. Conjugated bilirubin can spill back into serum and urine, giving dark urine [Pediatric Mid Chol Q8 · Old]. Too little pigment reaches the gut, producing pale/clay stools [Pediatric Mid Chol Q9 · Old] and defective fat absorption. Textbook direct fraction >15–20% is a teaching description. In infants, use age-appropriate absolute direct bilirubin thresholds and trends, and do not require the percentage threshold before referral.
Look for jaundice, hepatomegaly or hepatosplenomegaly, pruritus, steatorrhea, poor growth and fat-soluble vitamin A, D, E and K deficiency. Vitamin K deficiency can prolong INR. Longstanding disease can produce biliary cirrhosis and portal hypertension. Ask about stool and urine changes, onset, medicines, total parenteral nutrition, family history, infections and malformations. The book lists bradycardia among retention-associated findings. Severity and cause guide the urgency.
Etiology: intrahepatic and extrahepatic
Intrahepatic causes [Pediatric Mid Chol Q1/Q4/Q7] include sepsis, TORCH infections and viral hepatitis, metabolic disorders such as galactosemia, tyrosinemia, alpha-1 antitrypsin deficiency, CF and other inherited disorders, parenteral-nutrition-associated cholestasis, canalicular transporter defects, bile acid synthesis defects and idiopathic neonatal hepatitis. The source also lists fructosemia, Gaucher disease and umbilical catheterization as clinical associations; investigate the mechanism and patient context rather than assuming they are common causes. Alagille syndrome often combines paucity of interlobular bile ducts, characteristic facies and a systolic murmur [Pediatric Mid Chol Q10 · Old]. Think JAG1 or NOTCH2, peripheral pulmonary artery stenosis, butterfly vertebrae, posterior embryotoxon and renal/vascular disease.
Extrahepatic causes [Pediatric Mid Chol Q1/Q4/Q7] include biliary atresia, choledochal cyst, common bile duct stone, stenosis/stricture, inspissated bile or mucus plug and uncommon external compression. The textbook links congenital duct dilation to bile stasis, cholangitis and later complications. Choledochal cyst [Pediatric Mid Chol Q4/Q7] may appear as a cystic dilation on ultrasound and usually needs surgical assessment. Older patients with stones or strictures may undergo therapeutic ERCP [IM Dept p. 21 Q3] in appropriate hands.
Isolated conjugated bilirubin can reflect transport syndromes without typical progressive cholestatic injury. Dubin–Johnson syndrome has dark pigment in hepatocytes [Pediatric Mid Chol Q11 · Old] and involves ABCC2/MRP2. Rotor syndrome lacks black pigment and involves hepatic uptake/handling via OATP1B1/1B3. Gilbert and Crigler–Najjar are unconjugated patterns.
Investigations and severity
- Initial assessment
- Fractionated bilirubin, INR/glucose, liver enzymes/GGT and ultrasound
- Confirmation or next test
- Target the tests to age, obstruction and metabolic clues
Use fractionated bilirubin, ALT/AST, GGT and alkaline phosphatase [IM Dept p. 10 Q5 · Old p. 89 Q16], glucose, albumin and PT/INR. AST/ALT suggest injury, while INR and albumin help assess synthesis. ALP can be high from bone growth, so interpret it with GGT and age. High GGT can support obstruction, Alagille or some genetic cholestases; a normal/low GGT despite cholestasis suggests selected PFIC phenotypes or bile acid synthesis defects. PFIC comprises inherited transporter disorders. A low GGT is a pattern clue and is not an exclusion test for serious disease.
Ultrasound [Book II p. 346 · Old p. 112 Q40 comparison] is usually first-line for anatomy, gallbladder, cysts, duct dilation, stones and liver/vascular features. MRCP delineates ducts in selected cases; ERCP is invasive and can be therapeutic. HIDA, biopsy or cholangiography may be needed in selected children. Order directed cultures, metabolic tests, alpha-1 antitrypsin phenotype/genotype, and other testing based on age and phenotype. Check nutrition and vitamin status, with stool fat assessment when useful.
Pediatric acute liver failure [Pediatric Mid Chol Q2–3] involves acute injury without known chronic liver disease and coagulopathy not corrected by vitamin K, with INR ≥1.5 plus encephalopathy or ≥2 even without it. The course lists coagulopathy and encephalopathy as hallmarks. Any rapid worsening, altered mental status, hypoglycemia or persistent INR rise needs urgent hepatology/transplant-center evaluation.
Management and follow-up
Treat the cause and assess nutrition. Strategies include adequate energy, medium-chain triglycerides when useful, tailored fat-soluble vitamin supplementation and monitoring, treating sepsis, galactose restriction for classic galactosemia and relief of mechanical obstruction. Cholestyramine is a course option for selected cholestatic pruritus; consider interactions, deficiency and cause-specific therapies with specialists. Monitor growth, INR, liver chemistry, bone health and portal hypertension, and consider transplant for advanced disease. One older exam keys MRCP as the first image for suspected obstruction. In routine pediatric evaluation ultrasound usually comes first.
Exam traps
Biliary atresia, choledochal cyst and duct stones are extrahepatic examples. Sepsis, TORCH, galactosemia and Alagille belong on the intrahepatic list. A pale stool is an alarm and does not by itself distinguish a fixed blockage from severe intrahepatic cholestasis. A correctable INR suggests a deficiency component; persistence after vitamin K raises concern for synthetic failure.
Diagnostic and management pathways
- Jaundice → fractionate bilirubin and assess stool/urine, growth and severity
- Direct bilirubin elevated → INR, glucose, liver profile and ultrasound
- Infant or acholic stool → urgent biliary atresia pathway
- Route by anatomy and GGT/metabolic clues → selected MRCP, biopsy or cholangiography; treat cause and nutrition
Compare at a glance
| Pattern | Common clues | Examples |
|---|---|---|
| Extrahepatic impaired drainage | Acholic stools, dark urine, often high GGT | Biliary atresia, choledochal cyst, CBD stone |
| Intrahepatic cholestasis | Hepatomegaly, syndromic/infectious/metabolic clues | Alagille, sepsis, galactosemia, alpha-1 antitrypsin deficiency |
| Low/normal GGT cholestasis | Direct bilirubin elevated with low/normal GGT | Selected PFIC or bile acid synthesis defects |
| Isolated conjugated bilirubin | Often otherwise preserved synthetic function | Dubin–Johnson or Rotor |
| Predominantly unconjugated bilirubin | Urine without conjugated bilirubin | Hemolysis, Gilbert, Crigler–Najjar |
Supplementary clarification – not directly stated in the uploaded materials. Clinical references · NASPGHAN/ESPGHAN infant cholestasis guideline · NASPGHAN pediatric acute liver failure position paper
Exam words
- Cholestasis is impaired bile formation or flow [Old p. 78 Q19]
- dark urine [Pediatric Mid Chol Q8 · Old]
- pale/clay stools [Pediatric Mid Chol Q9 · Old]
- Intrahepatic causes [Pediatric Mid Chol Q1/Q4/Q7]
- paucity of interlobular bile ducts, characteristic facies and a systolic murmur [Pediatric Mid Chol Q10 · Old]
- Extrahepatic causes [Pediatric Mid Chol Q1/Q4/Q7]
- Choledochal cyst [Pediatric Mid Chol Q4/Q7]
- therapeutic ERCP [IM Dept p. 21 Q3]
- Dubin–Johnson syndrome has dark pigment in hepatocytes [Pediatric Mid Chol Q11 · Old]
- GGT and alkaline phosphatase [IM Dept p. 10 Q5 · Old p. 89 Q16]
- Ultrasound [Book II p. 346 · Old p. 112 Q40 comparison]
- Pediatric acute liver failure [Pediatric Mid Chol Q2–3]
Practice questions
Rapid revision sheet
Sixty-second recall. Say the definition, the key clue and the next clinical step out loud before checking the list.
- Cholestasis is impaired bile formation or flow [Old p. 78 Q19]
- dark urine [Pediatric Mid Chol Q8 · Old]
- pale/clay stools [Pediatric Mid Chol Q9 · Old]
- Intrahepatic causes [Pediatric Mid Chol Q1/Q4/Q7]
- paucity of interlobular bile ducts, characteristic facies and a systolic murmur [Pediatric Mid Chol Q10 · Old]
- Extrahepatic causes [Pediatric Mid Chol Q1/Q4/Q7]
Official College Textbook – Digestive Disorders – Part 2, pp. 345–347
Active recall
Why can urine become dark and stools pale in a child with cholestasis?
Water-soluble conjugated bilirubin enters urine, while reduced bile delivery to the intestine decreases stool pigment.
Official College Textbook – Digestive Disorders – Part 2, pp. 345–347
Recall the diagnostic and management pathway from memory.
Start with the presenting clue, name the first assessment, then distinguish confirmation, immediate management and follow-up.
- Jaundice → fractionate bilirubin and assess stool/urine, growth and severity
- Direct bilirubin elevated → INR, glucose, liver profile and ultrasound
- Infant or acholic stool → urgent biliary atresia pathway
- Route by anatomy and GGT/metabolic clues → selected MRCP, biopsy or cholangiography; treat cause and nutrition